Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain modulation in rheumatoid arthritis – Influence of adalimumab
2009-017163-42Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in rheumatoid arthritis (RA) comparing Adalimumab (Humira) with Placebo (2 arms). Primary endpoint: Central pain processing changes on fMRI. Started Mar 2010; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-017163-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017163-42.